These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2943814)

  • 1. Overview of clinical studies with hepatitis B vaccine made by recombinant DNA.
    Zajac BA; West DJ; McAleer WJ; Scolnick EM
    J Infect; 1986 Jul; 13 Suppl A():39-45. PubMed ID: 2943814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of yeast-derived hepatitis B vaccine from two different producers.
    Dahl-Hansen E; Siebke JC; Frøland SS; Degré M
    Epidemiol Infect; 1990 Feb; 104(1):143-9. PubMed ID: 2137785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody responses to recombinant, yeast-derived hepatitis B vaccine in teenage New Zealand children.
    Milne A; Moyes CD; Allwood GK; Pearce NE; Krugman S
    N Z Med J; 1988 Feb; 101(840):67-9. PubMed ID: 2967940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactogenicity and immunogenicity of a new recombinant yeast-derived hepatitis B vaccine.
    Scheiermann N; Gesemann KM; Paar D; Maurer C
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 269(3):411-21. PubMed ID: 2975448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody response after intradermal administration of recombinant hepatitis B vaccine in children.
    Wiström J; Gustafsson A
    Scand J Infect Dis; 1990; 22(5):621-2. PubMed ID: 2148015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of low doses of recombinant hepatitis B vaccine in young males.
    Tsakalakis C; Richardson SC; Roumeliotou-Karayannis A; Papaevangelou G
    Vaccine; 1988 Aug; 6(4):328-30. PubMed ID: 2973188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of a recombinant hepatitis B vaccine.
    Jilg W; Lorbeer B; Schmidt M; Wilske B; Zoulek G; Deinhardt F
    Lancet; 1984 Nov; 2(8413):1174-5. PubMed ID: 6150233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of a triple antigen and a single antigen recombinant vaccine for adult hepatitis B vaccination.
    Young MD; Gooch WM; Zuckerman AJ; Du W; Dickson B; Maddrey WC
    J Med Virol; 2001 Jul; 64(3):290-8. PubMed ID: 11424117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and safety in newborns of a new recombinant hepatitis B vaccine containing the S and pre-S2 antigens.
    Soulié JC; Devillier P; Santarelli J; Goudeau A; Vermeulen P; Guellier M; Saliou P; Hillion AM; Tron F; Huchet J
    Vaccine; 1991 Aug; 9(8):545-8. PubMed ID: 1837646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of a reduced dose of recombinant hepatitis B vaccine.
    Roumeliotou-Karayannis A; Dandolos E; Richardson SC; Papaevangelou G
    Vaccine; 1986 Jun; 4(2):93-4. PubMed ID: 2941929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore children: a four-year follow-up study.
    Goh KT; Tan KL; Kong KH; Oon CJ; Chan SH
    Bull World Health Organ; 1992; 70(2):233-9. PubMed ID: 1600584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low dose hepatitis B vaccination in children: benefit of low dose boosters.
    Milne A; Moyes CD; Dimitrakakis M
    N Z Med J; 1988 Jun; 101(847 Pt 1):370-1. PubMed ID: 2970604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of a low dose recombinant DNA hepatitis B vaccine in healthy adults in Singapore.
    Guan R; Tay HH; Yap I; Smith R; Tan LH
    Asian Pac J Allergy Immunol; 1989 Dec; 7(2):85-8. PubMed ID: 2533866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of recombinant hepatitis B vaccine in dialysis patients.
    Jilg W; Schmidt M; Weinel B; Küttler T; Brass H; Bommer J; Müller R; Schulte B; Schwarzbeck A; Deinhardt F
    J Hepatol; 1986; 3(2):190-5. PubMed ID: 3794300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of a recombinant yeast-derived hepatitis B vaccine (Engerix B) in children.
    Moyes C; Milne A
    N Z Med J; 1988 Apr; 101(843):162-4. PubMed ID: 2965799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the immunogenicity of reduced doses of two recombinant DNA hepatitis B vaccines in New Zealand children.
    Milne A; Brawner TA; Dumbill PC; Kawachi I; Pearce NE
    J Med Virol; 1989 Mar; 27(3):264-7. PubMed ID: 2524549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and safety of recombinant yeast-derived hepatitis B vaccine in haemodialysis patients.
    Fujiyama S; Yoshida K; Sato T; Shimada H; Deguchi T
    Hepatogastroenterology; 1990 Dec; 37 Suppl 2():140-4. PubMed ID: 2150664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant-yeast-derived hepatitis B vaccine in healthy adults: safety and two-year immunogenicity of early investigative lots of vaccine.
    Butterly L; Watkins E; Dienstag JL
    J Med Virol; 1989 Feb; 27(2):155-9. PubMed ID: 2522148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response to hepatitis B vaccine in infants and newborns: control trial in an endemic area (Senegal).
    Coursaget P; Deciron F; Tortey E; Barin F; Chiron JP; Yvonnet B; Diouf C; Denis F; Diop-Mar I; Correa P
    IARC Sci Publ; 1984; (63):319-35. PubMed ID: 6242150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the hepatitis B recombinant DNA yeast vaccine (H-B-VAX II) in children: two doses vs. three doses of 5 micrograms regime; an interim report.
    Lai CL; Yeoh EK; Chang WK; Lo VW; Ng LN
    J Infect; 1986 Jul; 13 Suppl A():19-25. PubMed ID: 2943812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.